
Narval
Amping up antibody therapeutics. Break the limits for monoclonal therapeutics with Antibody Mimetic Proteins™.
$4M Seed ·
Source: fundraisingfox.com
Funding history ↓Signals
Website registeredDec 28, 2022 (3 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | $4M | — | fundraisingfox.com |
Timeline
- Website created
Companies like Narval
TTubulis$360M Series B+ · Oct 2025SStar Therapeutics$200M Series B+ · Oct 2026
OOna Therapeutics$86.6M Series B+ · Oct 2026
KK2 Therapeutics$50M Seed · Aug 2026
TTriveni$65M Series B+ · Jun 2026CCrossbow Therapeutics$77M Series B+ · Mar 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/narval (get a free API key).